User Reviews for Mutamycin

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Filter by:

Learn more about Mutamycin.

Condition	Reviews	Compare	Avg. Ratings
Bladder Cancer	0 reviews	13 medications	Not rated - Be the first
Pancreatic Cancer	0 reviews	17 medications	Not rated - Be the first
Stomach Cancer	0 reviews	6 medications	Not rated - Be the first

Reviews for Mutamycin

There are no reviews - Be the first

Related Mutamycin Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Not yet classified

Approval History Drug history at FDA

FDA Consumer Updates

More FDA Updates...

Related Pages

Drug Class

Antibiotics/antineoplastics

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

Get Updates by Email

Email me about Mutamycin:

Related News and Articles

Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer 2 February 2012
Data Support Ongoing Phase 2 Study in Metastatic Bladder Cancer BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 2, 2012 /PRNewswire/ -- OncoGenex...
Popular Diabetes Drug Might Cut Pancreatic Cancer Risk: Study 31 January 2012
A new Swiss-American study indicates that long-term use of the popular diabetes medication metformin may lower the risk of developing pancreatic cancer, at...
Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer 30 January 2012
– Infinity Stops Phase 2 Study Following Preliminary Analysis Showing Trial Would Not Meet Primary Endpoint of Overall Survival – – No Unexpected...
Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI 20 January 2012
– Infinity to Review Saridegib Development Program on January 31, 2012, in New York City – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 20, 2012 -...
Blood Test Shows Promise in Spotting Pancreatic Cancers Early 17 January 2012
A new blood test may hold promise as a means of early detection and diagnosis for often deadly pancreatic cancers. Reporting Tuesday at the annual...

Help and Support

Looking for answers? Ask a question or go join the Mutamycin support group to connect with others who have similar interests.

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Advanced Phonetic
Search:

User Reviews for Mutamycin

Reviews for Mutamycin

See also...

Related Mutamycin Information